Early Stage Venture Solarea Bio Raises Series A of $11200000

October 18, 2020

About Solarea Bio

Solarea Bio develops microbial therapeutics aimed to treat indications derived from chronic inflammation to aid human health.

Website: Learn more on Solarea Bio’s website

Crunchbase: Follow on Crunchbase

[adace-ad id=”4426″]

Series A – Solarea Bio

Amount Raised11200000 USD
Announced Date2020-10-19
Equity Only FundingYes
Organization LocationCambridge, Massachusetts, United States, North America
Funding StatusEarly Stage Venture
Number of Funding Rounds2
Lead InvestorsBold Capital Partners, S2G Ventures
Number of Investors4
Number of Partner Investors2